In addition to brain pathology, recent studies have found that SNCA polymorphisms in PD patients modulate alpha-synuclein aggregation at the ENS before the occurrence of parkinsonian pathological changes in the brain in transgenic mouse models expressing pathogenic SNCA, consistent with Braak’s hypothesis [194, 195]. The gene discussed is SNCA; the disease is Parkinson disease.